ROIVANT SOCIAL VENTURES INC: Form 990, tax year 2021
View the entire original 990 at ProPublica ↗
- Organization
- ROIVANT SOCIAL VENTURES INC (EIN 83-3947490)
- Tax period
- 2021-04-01 to 2022-03-31
- Filed
- 2023-02-15
- IRS object ID
- 202330469349303453
- Schema version
- 2021v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-02-15T20:20:40-06:00 | ReturnTs |
| Tax Period End | 2022-03-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 871353108 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EISNER ADVISORY GROUP LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 733 THIRD AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100172703 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2021-04-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 833947490 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SOCIAL VENTURES INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ROIV | BusinessNameControlTxt |
| Phone | 9146349551 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 151 WEST 42ND STREET 15TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10036 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDSAY ANDROSKI | PersonNm |
| Person Title | PRESIDENT AND CEO | PersonTitleTxt |
| Phone | 9146349551 | PhoneNum |
| Signature | 2023-02-15 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | LINDSAY | PersonFirstNm |
| Person Last | ANDROSKI | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | CANDICE METH | PreparerPersonNm |
| PTIN | P01306891 | PTIN |
| Phone | 2129498700 | PhoneNum |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 0 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2021 | TaxYr |
| Build TS | 2023-03-07 01:45:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | LINDSAY ANDROSKI | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 151 WEST 42ND STREET 15TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10036 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $693,792 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ROIVANTSV.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2018 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | PROMOTE SYSTEMIC, SUSTAINED IMPROVEMENTS TO THE WAY HEALTHCARE IS ACCESSED AND DELIVERED | ActivityOrMissionDesc |
| Voting Members Governing Body | 5 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 5 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 15 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $23,041 | PYContributionsGrantsAmt |
| CY Contributions Grants | $684,276 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $0 | PYInvestmentIncomeAmt |
| CY Investment Income | $9,516 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $23,041 | PYTotalRevenueAmt |
| CY Total Revenue | $693,792 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $0 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $0 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $24,977 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $0 | PYOtherExpensesAmt |
| CY Other Expenses | $132,277 | CYOtherExpensesAmt |
| PY Total Expenses | $0 | PYTotalExpensesAmt |
| CY Total Expenses | $132,277 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $23,041 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $561,515 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $243 | TotalAssetsBOYAmt |
| Total Assets EOY | $838,064 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $0 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $276,306 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $243 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $561,758 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS USING INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $64,895 | ExpenseAmt |
| Desc | SEE SCHEDULE O. | Desc |
| Total Program Service Expenses | $64,895 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (1) | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 5 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 5 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 5 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | 0 | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | 0 | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMANDA WALDHAUSER | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2128476204 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 151 WEST 42ND STREET 15TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10036 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (5 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt |
|---|---|---|---|---|---|---|---|
| DANIEL PATTERSON | |||||||
| DIRECTOR | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $499,719 | $1,009,655 |
| RAKHI KUMAR | |||||||
| DIRECTOR AND TREASURER | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $1,714,451 | $1,537,625 |
| LINDSAY ANDROSKI | |||||||
| DIRECTOR, PRESIDENT AND CEO | 25.00 | 25.00 | Yes (X) | Yes (X) | $0 | $1,116,856 | $271,365 |
| ERIC VENKER | |||||||
| DIRECTOR AND CHAIR | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $3,178,901 | $23,346,834 |
| MATTHEW GLINE | |||||||
| DIRECTOR AND SECRETARY | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $6,971,426 | $27,301,494 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $0 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $13,481,353 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $53,466,973 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $87,777 | RelatedOrganizationsAmt |
| All Other Contributions | $596,499 | AllOtherContributionsAmt |
| Noncash Contributions | $87,777 | NoncashContributionsAmt |
| Total Contributions | $684,276 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $9,516 | TotalRevenueColumnAmt |
| Exclusion | $9,516 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $693,792 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $9,516 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $31,720 | TotalAmt |
| Program Services | $31,720 | ProgramServicesAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $19,285 | TotalAmt |
| Management And General | $19,285 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $76,169 | TotalAmt |
| Program Services | $33,175 | ProgramServicesAmt |
| Management And General | $22,848 | ManagementAndGeneralAmt |
| Fundraising | $20,146 | FundraisingAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | FundraisingFundraisingAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| SUBSCRIPTIONS | $4,611 | $4,611 | |
| FILING FEES | $272 | $272 | |
| BANK CHARGES | $220 | $220 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $132,277 | TotalAmt |
| Program Services | $64,895 | ProgramServicesAmt |
| Management And General | $42,405 | ManagementAndGeneralAmt |
| Fundraising | $24,977 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $243 | BOYAmt |
| EOY | $578,548 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $250,000 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $9,516 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $243 | BOYAmt |
| EOY | $838,064 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $26,306 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $250,000 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $276,306 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $243 | BOYAmt |
| EOY | $561,758 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $243 | BOYAmt |
| EOY | $561,758 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $243 | BOYAmt |
| EOY | $838,064 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $561,515 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | Yes (1) | AccountantCompileOrReviewInd |
Acct Compile Or Review Basis AcctCompileOrReviewBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus1 Year | $23,041 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $684,276 | CurrentTaxYearAmt |
| Total | $707,317 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus1 Year | $23,041 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $684,276 | CurrentTaxYearAmt |
| Total | $707,317 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $127,826 | SubstantialContributorsTotAmt |
| Public Support Total170 | $579,491 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $9,516 | CurrentTaxYearAmt |
| Total | $9,516 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $716,833 | TotalSupportAmt |
| First5 Years170 | Yes (X) | First5Years170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $2,877,711 | TotalRevEtcAuditedFinclStmtAmt |
| Donated Services And Use Fclts | $2,183,919 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $2,183,919 | RevenueNotReportedAmt |
| Revenue Subtotal | $693,792 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $693,792 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $2,316,196 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $2,183,919 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $2,183,919 | ExpensesNotReportedAmt |
| Expenses Subtotal | $132,277 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $132,277 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE ANY MATERIAL, UNCERTAIN TAX POSITIONS. TAX FILINGS FOR PERIODS ENDING MARCH 31, 2019, THE ORGANIZATION'S INITIAL FILING AND LATER ARE SUBJECT TO EXAMINATION BY APPLICABLE TAXING AUTHORITIES. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (1) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | Yes (1) | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MATTHEW GLINE | ||||||||||||||
| DIRECTOR AND SECRETARY | $0 | $628,141 | $0 | $455,000 | $0 | $5,888,285 | $0 | $27,276,449 | $0 | $25,045 | $0 | $34,272,920 | $0 | $0 |
| ERIC VENKER | ||||||||||||||
| DIRECTOR AND CHAIR | $0 | $554,069 | $0 | $353,438 | $0 | $2,271,394 | $0 | $23,326,136 | $0 | $20,698 | $0 | $26,525,735 | $0 | $0 |
| RAKHI KUMAR | ||||||||||||||
| DIRECTOR AND TREASURER | $0 | $343,925 | $0 | $515,000 | $0 | $855,526 | $0 | $1,500,935 | $0 | $36,690 | $0 | $3,252,076 | $0 | $0 |
| DANIEL PATTERSON | ||||||||||||||
| DIRECTOR | $0 | $228,698 | $0 | $100,000 | $0 | $171,021 | $0 | $999,552 | $0 | $10,103 | $0 | $1,509,374 | $0 | $0 |
| LINDSAY ANDROSKI | ||||||||||||||
| DIRECTOR, PRESIDENT AND CEO | $0 | $292,809 | $0 | $322,917 | $0 | $501,130 | $0 | $250,027 | $0 | $21,338 | $0 | $1,388,221 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3 | NO OFFICER IS COMPENSATED BY THE FOUNDATION. |
| PART I, LINES 4B-C | WHILE NO OFFICER IS COMPENSATED BY THE FILING ENTITY, OFFICERS HAVE BEEN COMPENSATED FOR THEIR WORK FOR A RELATED ENTITY THAT IS CONSIDERED A BROTHER/SISTER TO THE FILING ENTITY. THE RELATED ENTITY HAS BOTH A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN AND EQUITY BASED COMPENSATION FOR ITS EMPLOYEES, AS HAS BEEN DISCLOSED IN PART II. |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SCIENCES LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship With Org | CREATOR | RelationshipWithOrgTxt |
| Loan Purpose | TO ENABLE RSV TO FUND A LOAN TO UNRELATED ENTITY TO SUPPORT ITS PROGRAM | LoanPurposeTxt |
| Loan To Organization | Yes (X) | LoanToOrganizationInd |
| Original Principal | $250,000 | OriginalPrincipalAmt |
| Balance Due | $250,000 | BalanceDueAmt |
| Default | 0 | DefaultInd |
| Board Or Committee Approval | Yes (1) | BoardOrCommitteeApprovalInd |
| Written Agreement | Yes (1) | WrittenAgreementInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $250,000 | TotalBalanceDueAmt |
Schedule M IRS990ScheduleM
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | FORGIVENESS OF LOAN | Desc |
| Contribution | 1 | ContributionCnt |
| Noncash Contributions Rpt F990 | $87,777 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (B): | FormAndLineReferenceDesc |
| Explanation | THERE WAS ONE CONTRIBUTOR. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 3A | THE ORGANIZATION HAS THE FOLLOWING INITIATIVES FOR THE FISCAL-YEAR ENDING MARCH 31, 2022: (I) SEED INVESTMENT AND ADVISORY ASSISTANCE PROVIDED TO SUNFLOWER THERAPEUTICS, AN MIT SPINOUT WITH TECHNOLOGY THAT WILL ENABLE FLEXIBLE MANUFACTURING OF VACCINES, ANTIBODIES, AND BIOLOGICS (INCLUDING INSULIN) IN ROUGHLY THE SIZE OF A GALLEY KITCHEN. THIS PROJECT HAS THE POTENTIAL TO REVOLUTIONIZE ACCESS TO MEDICINES BY ENABLING LOW- AND MIDDLE-INCOME COUNTRIES, OR EVEN HEALTH DESERTS IN THE UNITED STATES, TO MEET A LOCAL POPULATION'S NEED FOR MEDICINES WITHOUT RELIANCE ON A GLOBAL SUPPLY CHAIN. (II) FOUNDING MEMBER OF GLOBAL GENE THERAPY INITIATIVE (GGTI), A GROUP OF DIVERSE STAKEHOLDERS INCLUDING CHARITABLE ORGANIZATIONS, ACADEMIA, INDUSTRY, AND GOVERNMENT WHOSE MISSION IS TO GET ACCESS FOR CELL AND GENE THERAPIES TO PEOPLE IN LOW- AND MIDDLE-INCOME COUNTRIES (LMIC), BRIDGING THE GAP TOWARDS HEALTH EQUITY. (III) PARTNERSHIP WITH THE DAVOS ALZHEIMER'S COLLABORATIVE TO DESIGN AND RUN THE FIRST ALZHEIMER'S CLINICAL TRIAL IN AFRICA. RSV WILL PROVIDE SHELVED DRUG MATERIAL TO BE USED IN THE CLINICAL TRIAL, ASSISTANCE IN DESIGNING THE CLINICAL TRIAL, AND DIGITAL HEALTH EXPERTISE TO IDENTIFY AND ENGAGE PARTNERS THAT CAN EXPAND THE TRIAL TO AFRICANS WITH SMARTPHONE ACCESS, BUT LIMITED ACCESS TO HOSPITALS. (IV) UNVEILED HANDS-ON DRUG DEVELOPMENT PROGRAM MODELED ON THE ROIVANT SCIENCES METHOD OF RAPIDLY IDENTIFYING AND TESTING PROMISING NEW DRUG CANDIDATES, TO BE HOUSED AT MULTIPLE ACADEMIC AND RESEARCH INSTITUTIONS. ANNOUNCEMENT OF SANFORD BURNHAM PREBYS AS FIRST INSTITUTIONAL PARTNER. THE PROGRAM SEEKS TO PROVIDE TALENTED STUDENTS WITH UNPARALLELED REAL-WORLD EXPERIENCE USING "SHELVED" DRUGS AS TEACHING TOOLS, WITH DUAL GOALS OF INCREASING DRUG DEVELOPMENT FOR UNMET NEEDS/UNDERSERVED PATIENT POPULATIONS AND INCREASING THE NUMBER OF DIVERSE EXECUTIVES IN THE BIOPHARMA INDUSTRY. (V) INCUBATION ASSISTANCE PROVIDED TO ENCORA THERAPEUTICS, AN MIT SPINOUT WITH A WEARABLE MECHANICAL DEVICE TO COUNTERACT ESSENTIAL TREMORS AND OTHER TYPES OF TREMORS (E.G. PARKINSON'S- INDUCED). CURRENT DEVICES ARE ELECTRONIC AND THEREFORE HAVE LENGTH OF USE LIMITATIONS (BURN RISK) AND CANNOT BE USED BY PATIENTS WITH PACEMAKERS OR OTHER ELECTRONIC EQUIPMENT. |
| FORM 990, PART VI, SECTION A, LINE 2 | EACH OF THE OFFICERS AND DIRECTORS ARE EMPLOYED BY ROIVANT SCIENCES INC. A WHOLLY CONTROLLED ENTITY OF ROIVANT SCIENCES LTD., THE FOUNDATION'S SOLE MEMBER. |
| FORM 990, PART VI, SECTION A, LINE 6 | ROIVANT FOUNDATION, INC. HAS A SOLE MEMBER ROIVANT SCIENCES LTD. |
| FORM 990, PART VI, SECTION A, LINE 7A | AS THE SOLE MEMBER, ROIVANT SCIENCES LTD. HAS THE RIGHT TO (I) APPROVE THE ELECTION OF DIRECTORS; (II) APPROVE THE NUMBER OF DIRECTORS COMPRISING THE BOARD OF DIRECTORS; (III) REMOVE DIRECTORS WITH OR WITHOUT CAUSE; (IV) APPROVE ANY AMENDMENT TO THE CERTIFICATE OF INCORPORATION OR BYLAWS OF THE CORPORATION ADOPTED BY THE BOARD OF DIRECTORS; (V)) APPROVE THE MERGER, SALE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS, DOMESTICATION, CONVERSION OR DISSOLUTION OF THE CORPORATION, IN EACH CASE AS ADOPTED BY THE BOARD OF DIRECTORS; AND (VI) VOTE FOR SUCH OTHER MATTERS AS MAY BE PROVIDED IN THESE BYLAWS OR THE PROVISIONS OF THE DELAWARE GENERAL CORPORATION LAW. |
| FORM 990, PART VI, SECTION A, LINE 8B | GIVEN THE SIZE OF THE FOUNDATION'S BOARD OF DIRECTORS, THERE ARE NO FORMAL COMMITEES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED AND APPROVED BY MANAGEMENT, AS WELL AS THE FOUNDATION'S PRESIDENT AND CEO PRIOR TO FILING. THE BOARD OF DIRECTORS ARE PROVIDED A COPY OF THE 990 PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL BOARD MEMBERS ARE REQUIRED TO REVIEW AND SIGN A CONFLICT-OF-INTEREST DOCUMENT AND CONFORM WITH THE FOUNDATION'S POLICY WHICH IS REGULARLY MONITORED AND ENFORCED FOR COMPLIANCE. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE FOUNDATION HAS NO EMPLOYEES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE FOUNDATION'S FINANCIAL STATEMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE FOUNDATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POOLICY ARE NOT OPEN FOR PUBLIC INSPECTION. |
| FORM 990, PART IX, LINE 11G | CONSULTING: PROGRAM SERVICE EXPENSES 33,175. MANAGEMENT AND GENERAL EXPENSES 6,648. FUNDRAISING EXPENSES 20,146. TOTAL EXPENSES 59,969. PUBLIC RELATIONS: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 16,200. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 16,200. |
Schedule R IRS990ScheduleR
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (118 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Controlled OrganizationControlledOrganizationInd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Legal Domicile StateLegalDomicileStateCd | Province Or StateForeignAddress/ProvinceOrStateNm | Direct Controlling NADirectControllingNACd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFFIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981565911 | SCIENTIFIC R&D | SZ | AFFIVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| AFFIVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981565694 | HOLDING COMPANY | UK | AFFIVANT SCIENCES LTD | C | 0 | |||||||
| AFFIVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981565414 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| AFFIVANT SCIENCES INC | ||||||||||||||||
| 853594557 | SCIENTIFIC R&D | AFFIVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ALYVANT GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981463962 | SCIENTIFIC R&D | SZ | ALYVANT HOLDINGS LIMITED | C | 0 | |||||||
| ALYVANT HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | HOLDING COMPANY | UK | ALYVANT LTD | C | 0 | ||||||||
| ALYVANT HOLDINGS INC | ||||||||||||||||
| 831257281 | HOLDING COMPANY | ALYVANT HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ALYVANT LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494184 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ALYVANT THERAPEUTICS INC | ||||||||||||||||
| 834535328 | SCIENTIFIC R&D | ALYVANT LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ALYVANT INC | ||||||||||||||||
| 825108735 | ADVERTISING MATERIAL | ALYVANT HOLDINGS INC | C | 0 | 151 W 42ND S | NEW YORK | NY | 10036 | DE | |||||||
| ARUVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | ARUVANT SCIENCES HOLDINGS LTD | C | 0 | ||||||||
| ARUVANT SCIENCES HOLDINGS LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466915 | HOLDING COMPANY | UK | ARUVANT SCIENCES LTD | C | 0 | |||||||
| ARUVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981490198 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ARUVANT SCIENCES INC | ||||||||||||||||
| 831984915 | SCIENTIFIC R&D | ARUVANT SCIENCES HOLDINGS LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| CYTOVANT BIOTECHNOLOGY CO LTD | ||||||||||||||||
| NO 356 ZHENGBO ROAD | SHANGHAI PILOT FREE TRADE ZONE | CH | 201308 | SCIENTIFIC R&D | CH | CYTOVANT SCIENCES CO LTD | C | 0 | LINGANG NEW AREA | |||||||
| CYTOVANT SCIENCES CO LTD | ||||||||||||||||
| NO 400 FANGCHUN ROAD | SHANGHAI PILOT FREE TRADE ZONE | CH | 200001 | SCIENTIFIC R&D | CH | CYTOVANT SCIENCES HK LIMITED | C | 0 | SHANGHAI | |||||||
| CYTOVANT SCIENCES HK LIMITED | ||||||||||||||||
| 9F THREE EXCHANGE SQUARE | CENTRAL HONG KONG | HK | 999077 | HOLDING COMPANY | HK | ROIVANT ASIA CELL THERAPY HOLDINGS LTD | C | 0 | CENTRAL HONG KONG | |||||||
| DERMAVANT HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468969 | HOLDING COMPANY | UK | DERMAVANT SCIENCES LTD | C | 0 | |||||||
| DERMAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | UK | 4051 | SCIENTIFIC R&D | SZ | DERMAVANT HOLDINGS LIMITED | C | 0 | ||||||||
| DERMAVANT SCIENCES IRL LIMITED | ||||||||||||||||
| ROCKTWIST HOUSE BLOCK 1 WESTERN BU | SHANNON CLARE | EI | V14 FW97 | SCIENTIFIC R&D | EI | DERMAVANT HOLDINGS LIMITED | C | 0 | ||||||||
| DERMAVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981465533 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| DERMAVANT SCIENCES INC | ||||||||||||||||
| 364835813 | SCIENTIFIC R&D | DERMAVANT HOLDINGS LIMITED | C | 0 | 3780 KILROY AIRPORT WAY | LONG BEACH | CA | 90806 | DE | |||||||
| DSL TREASURY HOLDINGS INC | ||||||||||||||||
| 852075395 | HOLDING COMPANY | DERMAVANT SCIENCES LTD | C | 0 | 3780 KILROY AIRPORT WAY | LONG BEACH | CA | 90806 | DE | |||||||
| DSL TREASURY INC | ||||||||||||||||
| 852103069 | HOLDING COMPANY | DSL TREASURY HOLDINGS INC | C | 0 | 3780 KILROY AIRPORT WAY | LONG BEACH | CA | 90806 | DE | |||||||
| EMAVANT SOLUTIONS GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981465559 | OTHER PROFESSIONAL, SCIENTIFIC & TECH | SZ | EMAVANT SOLUTIONS HOLDINGS LIMITED | C | 0 | |||||||
| EMAVANT SOLUTIONS HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468960 | HOLDING COMPANY | UK | EMAVANT SOLUTIONS LTD | C | 0 | |||||||
| EMAVANT SOLUTIONS LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981490144 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ENOLINK CO LTD | ||||||||||||||||
| 171 DOSAN-DAERO PSG BUILDING 12F | SEOUL | KS | 06037 | SCIENTIFIC R&D | KS | ENOVANT TECHNOLOGIES HOLDINGS LIMITED | C | 0 | SEOUL GANGNAM-GU | |||||||
| ENOVANT TECHNOLOGIES HK LIMITED | ||||||||||||||||
| 9F THREE EXCHANGE SQUARE 8 CONNAUG | CENTRAL HONG KONG | HK | 999077 | HOLDING COMPANY | HK | ENOVANT TECHNOLOGIES HOLDINGS LIMITED | C | 0 | ||||||||
| ENOVANT TECHNOLOGIES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466911 | HOLDING COMPANY | UK | ENOVANT TECHNOLOGIES LTD | C | 0 | |||||||
| ENOLINK HOLDINGS INC | ||||||||||||||||
| 832037272 | SCIENTIFIC R&D | ENOVANT TECHNOLOGIES HOLDINGS LIMITED | C | 0 | 245 MAIN ST | CAMBRIDGE | MA | 021420000 | DE | |||||||
| ENOVANT TECHNOLOGIES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981463963 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ENOLINK INC | ||||||||||||||||
| 832024107 | SCIENTIFIC R&D | ENOLINK HOLDINGS INC | C | 0 | 245 MAIN ST | CAMBRIDGE | MA | 021420000 | DE | |||||||
| GENEVANT SCIENCES BIOVENTURES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | GENEVANT SCIENCES GMBH | C | 0 | ||||||||
| GENEVANT SCIENCES CORPORATION | ||||||||||||||||
| 887 GRAND NORTHERN WAY | VANCOUVER | CA | VC6 3L6 | 981486273 | SCIENTIFIC R&D | CA | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | BRITISH COLUMBIA | ||||||
| GENEVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981468560 | SCIENTIFIC R&D | SZ | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| GENEVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466897 | HOLDING COMPANY | UK | GENEVANT SCIENCES LTD | C | 0 | |||||||
| GENEVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 371927500 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| GENEVANT SCIENCES INC | ||||||||||||||||
| 824617869 | SCIENTIFIC R&D | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | 245 MAIN ST | CAMBRIDGE | MA | 021420000 | DE | |||||||
| HEMAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | HEMAVANT SCIENCES HOLDINGS LIMITED | C | 0 | ||||||||
| HEMAVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981578379 | HOLDING COMPANY | UK | HEMAVANT SCIENCES LTD | C | 0 | |||||||
| HEMAVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981577750 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| HEMAVANT SCIENCES INC | ||||||||||||||||
| 874047801 | SCIENTIFIC R&D | HEMAVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| IMMUNO-020 GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981469961 | SCIENTIFIC R&D | SZ | IMMUNO-020 HOLDINGS LIMITED | C | 0 | |||||||
| IMMUNO-020 HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468547 | HOLDING COMPANY | UK | IMMUNO-020 LTD | C | 0 | |||||||
| IMMUNO-020 LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981492723 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| IMMUNOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981470927 | SCIENTIFIC R&D | SZ | IMMUNOVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| IMMUNOVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468959 | HOLDING COMPANY | UK | IMMUNOVANT SCIENCES LTD | C | 0 | |||||||
| IMMUNOVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494848 | HOLDING COMPANY | BD | IMMUNOVANT INC | C | 0 | |||||||
| IMMUNOVANT INC | ||||||||||||||||
| 832771572 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 320 W 37TH ST | NEW YORK | NY | 10018 | DE | |||||||
| IMVT CORPORATION | ||||||||||||||||
| 831251299 | SCIENTIFIC R&D | IMMUNOVANT SCIENCES HOLDINGS LIMITED | C | 0 | 321 W 37TH ST | NEW YORK | NY | 10018 | DE | |||||||
| INTERVANT INC | ||||||||||||||||
| 320659940 | HOLDING COMPANY | PRIOVANT HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| IZANA BIOSCIENCE LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | HOLDING COMPANY | UK | KINEVANT LTD | C | 0 | ||||||||
| KINEVANT LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981495584 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| KINEVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527962 | SCIENTIFIC R&D | SZ | KINEVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| KINEVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527842 | HOLDING COMPANY | UK | KINEVANT SCIENCES LTD | C | 0 | |||||||
| KINEVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494851 | HOLDING COMPANY | BD | KINEVANT LTD | C | 0 | |||||||
| KINEVANT SCIENCES INC | ||||||||||||||||
| 833172270 | SCIENTIFIC R&D | KINEVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| LOKAVANT HOLDINGS INC | ||||||||||||||||
| 843187613 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| LOKAVANT INC | ||||||||||||||||
| 843173963 | DATA PROCESSING SERVICE | LOKAVANT HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| LYSOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527959 | SCIENTIFIC R&D | SZ | LYSOVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| LYSOVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527858 | HOLDING COMPANY | UK | LYSOVANT SCIENCES LTD | C | 0 | |||||||
| LYSOVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494841 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| LYSOVANT SCIENCES INC | ||||||||||||||||
| 832733221 | SCIENTIFIC R&D | LYSOVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| METAVANT HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981470961 | HOLDING COMPANY | UK | METAVANT SCIENCES LTD | C | 0 | |||||||
| METAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981497075 | SCIENTIFIC R&D | SZ | METAVANT HOLDINGS LIMITED | C | 0 | |||||||
| METAVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981463971 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| METAVANT SCIENCES INC | ||||||||||||||||
| 364883199 | SCIENTIFIC R&D | METAVANT HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ONCOPIA THERAPEUTICS INC | ||||||||||||||||
| 821993382 | SCIENTIFIC R&D | PROTEOVANT SCIENCES INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| OPHTHOVANT HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466918 | HOLDING COMPANY | UK | OPHTHOVANT SCIENCES LTD | C | 0 | |||||||
| OPHTHOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981463954 | SCIENTIFIC R&D | SZ | OPHTHOVANT HOLDINGS LIMITED | C | 0 | |||||||
| OPHTHOVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527389 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| OPHTHOVANT SCIENCES INC | ||||||||||||||||
| 611860476 | SCIENTIFIC R&D | OPHTHOVANT HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PHARMAVANT 10 INC | ||||||||||||||||
| 874143208 | HOLDING COMPANY | ROIVANT SCIENCES INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PHARMAVANT 3 GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527951 | SCIENTIFIC R&D | SZ | PHARMAVANT 3 HOLDINGS LTD | C | 0 | |||||||
| PHARMAVANT 3 HOLDINGS LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527865 | HOLDING COMPANY | UK | KINEVANT LTD | C | 0 | |||||||
| PHARMAVANT 3 INC | ||||||||||||||||
| 852706725 | SCIENTIFIC R&D | PHARMAVANT 3 HOLDINGS LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PHARMAVANT 9 HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | HOLDING COMPANY | UK | PHARMAVANT 9 LTD | C | 0 | ||||||||
| PHARMAVANT 9 LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| PRIMAVANT GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527980 | OTHER PROFESSIONAL, SCIENTIFIC & TECHNICAL | SZ | PRIMAVANT HOLDINGS LTD | C | 0 | |||||||
| PRIMAVANT HOLDINGS LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527870 | HOLDING COMPANY | UK | PRIMAVANT LTD | C | 0 | |||||||
| PRIMAVANT LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | 981527381 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| PRIOVANT HOLDINGS INC | ||||||||||||||||
| 871233821 | BIOTECHNOLOGY R&D | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PRIOVANT THERAPEUTICS INC | ||||||||||||||||
| 871508551 | BIOTECHNOLOGY R&D | PRIOVANT HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PROTEOVANT SCIENCES INC | ||||||||||||||||
| 845089582 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| RCAC HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981590079 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| RESPIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981463957 | SCIENTIFIC R&D | SZ | RESPIVANT SCIENCES HOLDINGS LTD | C | 0 | |||||||
| RESPIVANT SCIENCES HOLDINGS LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981470825 | HOLDING COMPANY | UK | RESPIVANT SCIENCES LTD | C | 0 | |||||||
| RESPIVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981463960 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| RESPIVANT SCIENCES INC | ||||||||||||||||
| 831580422 | SCIENTIFIC R&D | RESPIVANT SCIENCES HOLDINGS LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| RHINE MERGER SUB INC | ||||||||||||||||
| 870917050 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT ASIA CELL THERAPY HOLDINGS LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| ROIVANT CHINA HOLDINGS LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | 981459587 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT DISCOVERY INC | ||||||||||||||||
| 862031998 | SCIENTIFIC R&D | ROIVANT SCIENCES INC | C | 0 | 451 D ST | BOSTON | MA | 022100000 | DE | |||||||
| ROIVANT HEPATOLOGY GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527964 | SCIENTIFIC R&D | SZ | ROIVANT HEPATOLOGY HOLDINGS LIMITED | C | 0 | |||||||
| ROIVANT HEPATOLOGY HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466920 | HOLDING COMPANY | UK | ROIVANT HEPATOLOGY LTD | C | 0 | |||||||
| ROIVANT HEPATOLOGY LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981493148 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT HEPATOLOGY INC | ||||||||||||||||
| 474243970 | SCIENTIFIC R&D | ROIVANT HEPATOLOGY HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT MS 2 LTD | ||||||||||||||||
| 2 CHURCH ST | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| ROIVANT RHINE HOLDINGS INC | ||||||||||||||||
| 851830874 | INVESTMENTS | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT SCIENCES ACQUISITION CORP | ||||||||||||||||
| PO BOX 309 UGLAND HOUSE | GRAND CAYMAN | CJ | KY1-1004 | 981585984 | HOLDING COMPANY | CJ | RSAC HOLDINGS LLC | C | 0 | |||||||
| ROIVANT SCIENCES CANADA INC | ||||||||||||||||
| 1600-925 WEST GEORGIA ST | VANCOUVER | CA | V6C 3L2 | SCIENTIFIC R&D | CA | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | BRITISH COLUMBIA | |||||||
| ROIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981506527 | SCIENTIFIC R&D | SZ | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| ROIVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468948 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT SCIENCES IRELAND LIMITED | ||||||||||||||||
| ROCKTWIST HOUSE BLOCK 1 WESTERN BU | SHANNON CLARE | EI | V14 FW97 | 981530399 | SCIENTIFIC R&D | EI | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| ROIVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY | LONDON | UK | SW1H 0DB | 981173944 | HOLDING COMPANY | BD | C | 0 | N/A | |||||||
| ROIVANT SCIENCES INC | ||||||||||||||||
| 465630757 | SCIENTIFIC R&D | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT TECHNOLOGY SUB 1 INC | ||||||||||||||||
| 863400527 | SCIENTIFIC R&D | ROIVANT SCIENCES INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT TREASURY HOLDINGS INC | ||||||||||||||||
| 824789074 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT TREASURY INC | ||||||||||||||||
| 824794439 | SCIENTIFIC R&D | ROIVANT TREASURY HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| RSAC HOLDINGS LLC | ||||||||||||||||
| PO BOX 309 UGLAND HOUSE | GRAND CAYMAN | CJ | KY1-1004 | 981586006 | HOLDING COMPANY | CJ | RCAC HOLDINGS LIMITED | C | 0 | |||||||
| SILICON TX CHINA CO LTD | ||||||||||||||||
| NO 2288 WUZHONG AVENUE | YUEXI | CH | 999077 | SCIENTIFIC R&D | CH | SILICON TX HOLDINGS HK LIMITED | C | 0 | WUZHOND DISTRICT, | |||||||
| SILICON TX HOLDINGS HK LIMITED | ||||||||||||||||
| FAIRMONT HOUSE NO 8 COTTON TREE D | ADMIRALTY | CH | 999077 | HOLDING COMPANY | HK | ROIVANT MS 2 LTD | C | 0 | HONG KONG | |||||||
| SINOVANT SCIENCES CO LTD | ||||||||||||||||
| NO 400 FANGCHUN RD | SHANGHAI | CH | 201203 | SCIENTIFIC R&D | CH | SINOVANT SCIENCES HK LIMITED | C | 0 | ||||||||
| SINOVANT SCIENCES HK LIMITED | ||||||||||||||||
| 9F THREE EXCHANGE SQUARE | CENTRAL HONG KONG | CH | 999077 | HOLDING COMPANY | HK | ROIVANT CHINA HOLDINGS LTD | C | 0 | HONG KONG | |||||||
| SUZHOU ANBAO PHARMACEUTICAL COLTD | ||||||||||||||||
| SUZHOU INDUSTRIAL PARK STAR LAKE 21 | NANOTECHNOLOGY PARK | CH | R15 CH | PHARMACEUTICALS | CH | ONCOPIA THERAPEUTICS INC | C | 0 | SUZHOU | |||||||
| VANTAI HOLDINGS INC | ||||||||||||||||
| 843434923 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| VANTAI INC | ||||||||||||||||
| 843426285 | DATA ANALYTICS | VANTAI HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | Yes (1) | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (4 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| ROIVANT SCIENCES LTD | ||
| C | $87,777 | FMV |
| ROIVANT SCIENCES LTD | ||
| E | $250,000 | FMV |
| ROIVANT SCIENCES LTD | ||
| N | ||
| ROIVANT SCIENCES LTD | ||
| O | ||